logo
Plus   Neg
Share
Email

Sanofi, GSK Begin Phase 1/2 Clinical Trial For Adjuvanted COVID-19 Vaccine Candidate - Quick Facts

Sanofi (SNY) and GlaxoSmithKline plc (GSK.L,GSK) announced the start of Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine, with total of 440 healthy adults being enrolled across 11 investigational sites in the United States.

The vaccine candidate uses the same recombinant protein-based technology as one of Sanofi's seasonal influenza vaccines with GSK's pandemic adjuvant technology.

The companies expect first results early December 2020 which will support the initiation of a Phase 3 trial in December 2020, with the plan to seek regulatory approval in the first half of 2021.

Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur, said, "The initiation of our clinical study is an important step and brings us closer to a potential vaccine which could help defeat COVID-19. Our dedicated teams and partner continue to work around the clock as we aim to deliver the first results in early December. Positive data will enable a prompt start of the pivotal phase 3 trial by the end of this year."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Eli Lilly and Co. (LLY) will end a phase III clinical trial for its COVID-19 antibody treatment in the U.S., due to insufficient evidence on improved clinical outcomes. Orca Bay Foods, LLC recalled about 4,450 pounds of Trader Joe's brand Gluten Free Battered Halibut products for undeclared wheat and milk allergens, according to a statement published by the U.S. Food and Drug Administration (FDA). The action was initiated after it was discovered that product containing Wheat and Milk was distributed in packaging. Lee Kun-hee, the Chairman of South Korean conglomerate Samsung Group, has died on October 25, at the age of 78. It was he who transformed Samsung into a South Korean behemoth, and the world's largest manufacturer of smartphones, televisions, and semiconductors. As per reports, Lee's only son Jae-yong, who currently serves as vice chairman of Samsung Electronics, is likely to take over Samsung.
Follow RTT